CLPT vs CMA
Clearpoint Neuro Inc (CLPT) versus CMA (CMA) — a side-by-side from cached financials, not a winner call.
Clearpoint Neuro Inc (CLPT) is a medical devices company listed on US.
CMA (CMA) common stock.
Latest reported CLPT revenue for 2026-06-30 was $23.0M. Net income was -$20.9M. Revenue was up 89.7% from 2026-03-31 to 2026-06-30. CLPT currently screens at market cap $371.0M.
CMA does not have a complete income-statement cache yet.
CLPT currently screens at market cap $371.0M.
Not investment advice. Open the CLPT and CMA stock pages for the full models.
Not investment advice.